Budget cuts could slash inspections

Share this article:

FDA's top enforcer has warned that cuts to the agency's budget now being contemplated by some in Congress could result in as many as 2,000 fewer domestic and foreign inspections of pharmaceutical plants and food processing facilities, and up to 9,000 fewer border inspections for FDA-regulated drug and food imports.

Associate commissioner for regulatory affairs Dara Corrigan told a meeting of the Alliance for a Stronger FDA that the magnitude and increasing complexity of the task confronting her office can be seen in the past year's 200 recall “events” involving 860 products, and consisting of 340 million product units—all with a staff of 19 product recall managers.

As a result of a FY 2008 supplement to FDA's budget, augmented by FY 2009 appropriations and a continued supplement in FY 2010, Corrigan's office was able to increase its inspectional force by approximately 800 new investigators, Corrigan said. However, she indicated that subsequent staff attrition, including retirements, has reduced this initial increase in staff by more than half.

Share this article:

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...